1. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase mRNA expression in streptozotocin-diabetic rats
    V. G. Mykhalchenko et al, 2008, Biopolymers and Cell CrossRef
  2. Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
    Xiaoting Luo et al, 2016, Aging and disease CrossRef
  3. A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications
    Rishabh A. Babel et al, 2021, Current Diabetes Reviews CrossRef
  4. Low-Dose Poly(ADP-Ribose) Polymerase Inhibitor-Containing Combination Therapies Reverse Early Peripheral Diabetic Neuropathy
    Fei Li et al, 2005, Diabetes CrossRef
  5. Low-Density Lipoprotein Receptor-Related Protein-1 Signaling in Angiogenesis
    Hua Mao et al, 2017, Frontiers in Cardiovascular Medicine CrossRef
  6. PARP Inhibitor Protects Against Chronic Hypoxia/Reoxygenation-Induced Retinal Injury by Regulation of MAPKs, HIF1α, Nrf2, and NFκB
    Krisztina Kovacs et al, 2019, Investigative Opthalmology & Visual Science CrossRef
  7. A Promising Combination: PACAP and PARP Inhibitor Have Therapeutic Potential in Models of Diabetic and Hypertensive Retinopathies
    Etelka Pöstyéni et al, 2021, Cells CrossRef
  8. Nitric Oxide and Peroxynitrite in Health and Disease
    Pál Pacher et al, 2007, Physiological Reviews CrossRef
  9. Aldose Reductase Inhibition Counteracts Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase Activation in Tissue Sites for Diabetes Complications
    Irina G. Obrosova et al, 2005, Diabetes CrossRef
  10. Role of Glyceraldehyde 3-Phosphate Dehydrogenase in the Development and Progression of Diabetic Retinopathy
    Mamta Kanwar et al, 2009, Diabetes CrossRef